Evidence map›Paper›PMID 31003440›Full record

ReviewCancers2019

Targeting Wnt Signaling via Notch in Intestinal Carcinogenesis.

Elke Kaemmerer, Min Kyung Jeon, Alexander Berndt, Christian Liedtke, Nikolaus Gassler

Abstract readReview
In one paragraph

Review in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Intestinal Wnt in the transition from physiology to oncology.World journal of clinical oncology · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Combined effect of vitamin C and vitamin DNutrition & metabolism · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elke KaemmererInstitute of Pathology, RWTH Aachen University, 52074 Aachen, Germany. ekaemmerer@ukaachen.de.
Min Kyung JeonDivision of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul 03722, Korea. mkjeon@yuhs.ac.
Alexander BerndtSection Pathology, Institute of Legal Medicine, University Hospital Jena, 07747 Jena, Germany. alexander.berndt@med.uni-jena.de.
Christian LiedtkeDepartment of Medicine III, RWTH Aachen University, 52074 Aachen, Germany. cliedtke@ukaachen.de.ORCID 0000-0003-4681-7887
Nikolaus GasslerInstitute of Pathology, RWTH Aachen University, 52074 Aachen, Germany. ngassler@ukaachen.de.

Funding

Deutsche Forschungsgemeinschaft DFG GA 785/5-1
6 · The paper itself

Abstract

Proliferation and differentiation of intestinal epithelial cells is assisted by highly specialized and well-regulated signaling cascades. The Wnt pathway, which is one of the fundamental pathways in the intestine, contributes to the organization of proliferative intestinal crypts by positioning and cycling of intestinal stem cells and their derivatives. The Wnt pathway promotes differentiation of intestinal secretory cell types along the crypt-plateau and crypt-villus axis. In contrast to the Wnt pathway, the intestinal Notch cascade participates in cellular differentiation and directs progenitor cells towards an absorptive fate with diminished numbers of Paneth and goblet cells. Opposing activities of Notch and Wnt signaling in the regulation of intestinal stem cells and the enterocytic cell fate have been elucidated recently. In fact, targeting Notch was able to overcome tumorigenesis of intestinal adenomas, prevented carcinogenesis, and counteracted Paneth cell death in the absence of caspase 8. At present, pharmacological Notch inhibition is considered as an interesting tool targeting the intrinsic Wnt pathway activities in intestinal non-neoplastic disease and carcinogenesis.

Indexed as

cancercaspase 8intestinelncRNANotchtargetingWnt

Identifiers

PMID31003440
PMCPMC6520938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.